| Hepatitis E virus and neurologic disorders N Kamar, RP Bendall, JM Peron, P Cintas, L Prudhomme, JM Mansuy, ... Emerging infectious diseases 17 (2), 173, 2011 | 378 | 2011 |
| Hepatitis E virus and neurological injury HR Dalton, N Kamar, JJJ Van Eijk, BN Mclean, P Cintas, RP Bendall, ... Nature Reviews Neurology 12 (2), 77, 2016 | 236 | 2016 |
| Causes of death amongst French patients with amyotrophic lateral sclerosis: a prospective study J Gil, B Funalot, A Verschueren, V Danel‐Brunaud, W Camu, ... European journal of neurology 15 (11), 1245-1251, 2008 | 196 | 2008 |
| Hepatitis E virus‐induced neurological symptoms in a kidney‐transplant patient with chronic hepatitis N Kamar, J Izopet, P Cintas, C Garrouste, E Uro‐Coste, O Cointault, ... American Journal of Transplantation 10 (5), 1321-1324, 2010 | 180 | 2010 |
| Development and validation of a new risk prediction score for life-threatening ventricular tachyarrhythmias in laminopathies K Wahbi, R Ben Yaou, E Gandjbakhch, F Anselme, T Gossios, ... Circulation 140 (4), 293-302, 2019 | 161 | 2019 |
| Gender as a modifying factor influencing myotonic dystrophy type 1 phenotype severity and mortality: a nationwide multiple databases cross-sectional observational study C Dogan, M De Antonio, D Hamroun, H Varet, M Fabbro, F Rougier, ... PloS one 11 (2), e0148264, 2016 | 157 | 2016 |
| High rate of recanalization of middle cerebral artery occlusion during 2-MHz transcranial color-coded Doppler continuous monitoring without thrombolytic drug P Cintas, AP Le Traon, V Larrue Stroke 33 (2), 626-628, 2002 | 135 | 2002 |
| Enhancement of enzymatic fibrinolysis with 2‐MHz ultrasound and microbubbles P Cintas, F Nguyen, B Boneu, V Larrue Journal of Thrombosis and Haemostasis 2 (7), 1163-1166, 2004 | 131 | 2004 |
| Mutation Update and Genotype–Phenotype Correlations of Novel and Previously Described Mutations in TPM2 and TPM3 Causing Congenital Myopathies M Marttila, VL Lehtokari, S Marston, TA Nyman, C Barnerias, AH Beggs, ... Human mutation 35 (7), 779-790, 2014 | 113 | 2014 |
| Hepatitis E virus infection and acute non-traumatic neurological injury: a prospective multicentre study HR Dalton, JJJ van Eijk, P Cintas, RG Madden, C Jones, GW Webb, ... Journal of hepatology 67 (5), 925-932, 2017 | 100 | 2017 |
| Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases Network G Solé, E Salort-Campana, Y Pereon, T Stojkovic, K Wahbi, P Cintas, ... Revue neurologique 176 (6), 507-515, 2020 | 95 | 2020 |
| Atrial fibrillation and subtype of atrial fibrillation in cardiac amyloidosis: clinical and echocardiographic features, impact on mortality K Sanchis, E Cariou, M Colombat, D Ribes, A Huart, P Cintas, P Fournier, ... Amyloid 26 (3), 128-138, 2019 | 76 | 2019 |
| Acute hepatitis E in French patients and neurological manifestations F Abravanel, J Pique, E Couturier, F Nicot, C Dimeglio, S Lhomme, ... Journal of Infection 77 (3), 220-226, 2018 | 75 | 2018 |
| Neurologic disorders in immunocompetent patients with autochthonous acute hepatitis E HB Perrin, P Cintas, F Abravanel, R Gerolami, L d'Alteroche, JN Raynal, ... Emerging Infectious Diseases 21 (11), 1928, 2015 | 74 | 2015 |
| Increased exposure to statins in patients developing chronic muscle diseases: a 2-year retrospective study L Sailler, C Pereira, A Bagheri, M Lapeyre-Mestre, JL Montastruc, P Arlet, ... Annals of the rheumatic diseases 67 (5), 614-619, 2008 | 56 | 2008 |
| Bent spine syndrome (camptocormia): a retrospective study of 63 patients M Laroche, P Cintas Joint Bone Spine 77 (6), 593-596, 2010 | 55 | 2010 |
| Impact of coronavirus disease 2019 in a French cohort of myasthenia gravis G Solé, S Mathis, D Friedman, E Salort-Campana, C Tard, F Bouhour, ... Neurology 96 (16), e2109-e2120, 2021 | 53 | 2021 |
| Which method for diagnosing small fiber neuropathy? V Fabry, A Gerdelat, B Acket, P Cintas, V Rousseau, E Uro-Coste, ... Frontiers in Neurology 11, 342, 2020 | 51 | 2020 |
| Adult Niemann-Pick disease type C in France: clinical phenotypes and long-term miglustat treatment effect Y Nadjar, AL Hütter-Moncada, P Latour, X Ayrignac, E Kaphan, ... Orphanet journal of rare diseases 13, 1-12, 2018 | 49 | 2018 |
| Dehydroepiandrosterone for myotonic dystrophy type 1 I Pénisson-Besnier, M Devillers, R Porcher, D Orlikowski, V Doppler, ... Neurology 71 (6), 407-412, 2008 | 38 | 2008 |
